Genome-wide Repeat Landscapes in Cancer and Cell-free DNA
Overview
Authors
Affiliations
Genetic changes in repetitive sequences are a hallmark of cancer and other diseases, but characterizing these has been challenging using standard sequencing approaches. We developed a de novo kmer finding approach, called ARTEMIS (Analysis of RepeaT EleMents in dISease), to identify repeat elements from whole-genome sequencing. Using this method, we analyzed 1.2 billion kmers in 2837 tissue and plasma samples from 1975 patients, including those with lung, breast, colorectal, ovarian, liver, gastric, head and neck, bladder, cervical, thyroid, or prostate cancer. We identified tumor-specific changes in these patients in 1280 repeat element types from the LINE, SINE, LTR, transposable element, and human satellite families. These included changes to known repeats and 820 elements that were not previously known to be altered in human cancer. Repeat elements were enriched in regions of driver genes, and their representation was altered by structural changes and epigenetic states. Machine learning analyses of genome-wide repeat landscapes and fragmentation profiles in cfDNA detected patients with early-stage lung or liver cancer in cross-validated and externally validated cohorts. In addition, these repeat landscapes could be used to noninvasively identify the tissue of origin of tumors. These analyses reveal widespread changes in repeat landscapes of human cancers and provide an approach for their detection and characterization that could benefit early detection and disease monitoring of patients with cancer.
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.
Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V Nat Rev Cancer. 2025; .
PMID: 40038442 DOI: 10.1038/s41568-025-00795-x.
Artificial intelligence and machine learning in cell-free-DNA-based diagnostics.
Tsui W, Ding S, Jiang P, Lo Y Genome Res. 2025; 35(1):1-19.
PMID: 39843210 PMC: 11789496. DOI: 10.1101/gr.278413.123.
Normanno N, Morabito A, Rachiglio A, Sforza V, Landi L, Bria E Nat Rev Clin Oncol. 2025; 22(3):215-231.
PMID: 39833354 DOI: 10.1038/s41571-024-00985-w.
Artificial intelligence in lung cancer: current applications, future perspectives, and challenges.
Huang D, Li Z, Jiang T, Yang C, Li N Front Oncol. 2025; 14:1486310.
PMID: 39763611 PMC: 11700796. DOI: 10.3389/fonc.2024.1486310.
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.
Medina J, Annapragada A, Lof P, Short S, Bartolomucci A, Mathios D Cancer Discov. 2024; 15(1):105-118.
PMID: 39345137 PMC: 11726017. DOI: 10.1158/2159-8290.CD-24-0393.